- Home
- IMCC vs PSTV Comparison
IMCC vs PSTV Comparison
Compare IMCC & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- PSTV
- Stock Information
- Founded
- IMCC 1980
- PSTV 1996
- Country
- IMCC Israel
- PSTV United States
- Employees
- IMCC N/A
- PSTV N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- PSTV Medical/Dental Instruments
- Sector
- IMCC Health Care
- PSTV Health Care
- Exchange
- IMCC Nasdaq
- PSTV Nasdaq
- Market Cap
- IMCC 12.0M
- PSTV 10.4M
- IPO Year
- IMCC N/A
- PSTV N/A
- Fundamental
- Price
- IMCC $2.95
- PSTV $0.35
- Analyst Decision
- IMCC
- PSTV Strong Buy
- Analyst Count
- IMCC 0
- PSTV 3
- Target Price
- IMCC N/A
- PSTV $10.83
- AVG Volume (30 Days)
- IMCC 148.9K
- PSTV 65.3M
- Earning Date
- IMCC 08-13-2025
- PSTV 08-13-2025
- Dividend Yield
- IMCC N/A
- PSTV N/A
- EPS Growth
- IMCC N/A
- PSTV N/A
- EPS
- IMCC N/A
- PSTV N/A
- Revenue
- IMCC $37,894,737.00
- PSTV $5,206,000.00
- Revenue This Year
- IMCC $47.12
- PSTV $14.10
- Revenue Next Year
- IMCC $12.83
- PSTV $7.96
- P/E Ratio
- IMCC N/A
- PSTV N/A
- Revenue Growth
- IMCC 12.68
- PSTV N/A
- 52 Week Low
- IMCC $1.29
- PSTV $0.16
- 52 Week High
- IMCC $7.12
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- IMCC 51.60
- PSTV 51.85
- Support Level
- IMCC $2.37
- PSTV $0.27
- Resistance Level
- IMCC $3.75
- PSTV $0.37
- Average True Range (ATR)
- IMCC 0.38
- PSTV 0.05
- MACD
- IMCC 0.03
- PSTV 0.02
- Stochastic Oscillator
- IMCC 41.99
- PSTV 67.04
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).